• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NamePALMAZ BALLOON-EXPANDABLE STENT
Classification Namestent, coronary
Generic Nameiliac stent
ApplicantCORDIS CORP.
PMA NumberP890017
Supplement NumberS010
Date Received12/06/2001
Decision Date07/10/2002
Product Code
MAF[ Registered Establishments with MAF ]
Docket Number 02M-0348
Notice Date 08/08/2002
Advisory Committee Cardiovascular
Supplement Typepanel track
Supplement Reason labeling change - indications
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the cordis palmaz balloon expandable stent (models p104r, p154r, p204r). The device is indicated for use in patients with atherosclerotic disease of the renal arteries following suboptimal percutaneous renal angioplasty (ptra) of a de novo or restenotic lesion (<=22 mm in length) located within 10 mm of the aortorenal artery border and with a reference vessel diameter of >= 4 mm and <= 8 mm. Suboptimal ptra results are defined by one or more of the following unfavorable results: >= 50% residual stenosis by visual estimate, >= 20 mm hg peak translesional pressure gradient, >= 10 mm hg mean translesional pressure gradient, and/or grade d dissection (a spiral shaped filling defect within the lumen of the vessel) or any dissection with significant compromise in lumen flow.
Approval Order Approval Order
-
-